Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Solara Active Pharma Sciences Ltd.
Press Release Nov 01 2022
Business
Nov 1 2022
4 min read

Press Release Nov 01 2022

Solara Active Pharma Sciences Limited has informed the Exchange about press release dated 01-Nov-2022 titled Solara receives European Approval (CEP) to manufacture Ibuprofen from its flagship Vizag facility

View Attachment